Screening for HCV infection in jails

JAMA

Volumn 307, Issue 12, 2012, Pages 1259-1260

  Spaulding, Anne C ^a   Thomas, David L ^b  

^a EMORY UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEPATITIS C; HUMAN; PATIENT COUNSELING; PATIENT IDENTIFICATION; POINT OF CARE TESTING; PRIORITY JOURNAL; PRISON; SCREENING TEST; SHORT SURVEY; AGE; ARTICLE; MANDATORY PROGRAM; MASS SCREENING; PRISONER; RISK FACTOR; TIME; UNITED STATES;

AGE FACTORS; HEPATITIS C; HUMANS; MANDATORY PROGRAMS; MASS SCREENING; PRISONERS; PRISONS; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 84859207626     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.374     Document Type: Short Survey

References (10)

1. Weinbaum C, Lyerla R, Margolis HS; Centers for Disease Control and Prevention. Prevention and control of infections with hepatitis viruses in correctional settings. MMWR Recomm Rep. 2003;52(RR-1):1-36.
2. Colvin HM, Mitchell AE. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. http://www.cdc.gov/hepatitis/ PDFs/IOM-HepatitisAndLiverCancerReport.pdf. Accessed June 14, 2010.
3. Spaulding AC, Seals RM, Page MJ, Brzozowski AK, Rhodes W, Hammett TM. HIV/AIDS among inmates of and releasees from US correctional facilities, 2006: declining share of epidemic but persistent public health opportunity. PLoS One. 2009;4(11):e7558. doi:10.1371/journal.pone.0007558.
4. Spaulding A, Greene C, Davidson K, Schneidermann M, Rich J. Hepatitis C in state correctional facilities. Prev Med. 1999;28(1):92-100. (Pubitemid 29372094)
5. Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB; American Association for Study of Liver Diseases. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for Study of Liver Diseases. Hepatology. 2011;54(4):1433-1444.
6. Arora S, Thornton K, Murata G, et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med. 2011;364(23):2199- 2207.
7. Lok AS, Gardiner DF, Lawitz E, et al. Preliminary study of two antiviral agents for hepatitis C genotype 1. N Engl J Med. 2012;366(3):216-224.
8. Flanigan TP, Zaller N, Beckwith CG, et al. Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention. J Acquir Immune Defic Syndr. 2010;55(suppl 2):S78-S83. doi:10.1097/QAI.1090b1013e3181fbc1094f.
9. US Dept of Health & Human Services. Combating the silent epidemic of viral hepatitis: action plan for the prevention, care and treatment of viral hepatitis. http://www.hhs.gov/ash/initiatives/hepatitis/. Accessed February 22, 2012.
10. Rein DB, Smith BD, Wittenborn JS, et al. The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings. Ann Intern Med. 2012;156(4):263-270.